Pemetrexed Injection 500 mg is taken into use curing malignant pleural mesothelioma in people, whose illness is unresectable; like a single agent for the primary treatment of nearby progressive or metastatic non-small cell lung cancer following prior chemotherapy; in grouping with cisplatin for curing of locally progressive or metastatic non-squamous non-small cell lung cancer; to maintain treatment of people with nearby progressive or metastatic non-squamous non-small cell lung cancer whose illness has not developed following 4 cycles of platinum built first-line chemotherapy.
Additional Information :
IV Suggested dose is 500 mg/m 2 infused for approximately10 min on day 1 of every 21-day cycle.
Side Effects :
Cardiovascular: Supraventricular arrhythmia (less than 1%).
CNS: Sensory neuropathy (9%); fatigue (34%); motor neuropathy (1% to 5%).